pursuant to their Preferred Return (such fraction to be equal to the portion of the Units held by the ProfitsSanofi ODYSSEY Phase 3 Clinical Trial Overview for Praluent
Case Filed-33619House OversightGUID: BSFD8858-33DC-4DD5-9403-CAF283CC25D5
January 1, 20250p
Case File
d-33619House OversightGUID: BSFD8858-33DC-4DD5-9403-CAF283CC25D5
Date
January 1, 2025
Source
House Oversight
Reference
d-33619
Pages
0
Persons
0
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.